Abstract
The paper focuses on the synthesis of mind-sets for patients who are undergoing clinical trials with weight-reducing drugs. The objective is to demonstrate how LLMs, large language models, can be combined with Mind Genomics thinking to better understand how patients in these clinical trials may think. Although the data are simulated, the outcome provides a way for the clinician and the drug manufacturer, as well as the participating physician, to understand the deeper thoughts of the study participants. As such, the approach is presented as a didactic tool to introduce the minds of patients as people to clinicians and to drug companies, doing so in the same spirit as consumer researchers seek to understand the corporation’s customers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
